Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the gloria–af registry

HIGHLIGHTS

• What: The study aimed to determine differences in cardiovascular (CV) outcomes and death rates among patients with atrial fibrillation (AF) who were prescribed with beta-blockers digoxin or combination therapy. In the analysis , stabilised weight was calculated and assigned to each participant according to the participant`s probability of receiving his/her own treatment regimen (Beta-blockers alone vs Digoxin alone vs Beta-blockers and amp; Digoxin) which was created by generalised linear model.
• Who: Steven Ho Man Lam from the Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.